{
    "Trade/Device Name(s)": [
        "BD Veritor\u2122 System Flu A+B Assay",
        "BD Veritor\u2122 System for Rapid Detection of Flu A+B"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K133138",
    "Predicate Device Reference 510(k) Number(s)": [
        "K120049",
        "K121797",
        "K132256",
        "K132692"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "September 26, 2013",
    "Summary Letter Received Date": "October 17, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal wash",
        "Nasopharyngeal aspirate",
        "Nasopharyngeal swab in transport media"
    ],
    "Specimen Container(s)": [
        "Transport media tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Veritor\u2122 System Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay"
    ],
    "Methodologies": [
        "Antigen detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Reader",
        "Device",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System Flu A+B rapid chromatographic immunoassay for detection of influenza A and B viral antigens",
    "Indications for Use Summary": "Rapid chromatographic immunoassay for direct and qualitative detection and differentiation of influenza A and B viral nucleoprotein antigens from nasopharyngeal wash, aspirate, and swab samples from symptomatic patients to aid in diagnosis of influenza A and B infections",
    "fda_folder": "Microbiology"
}